UBS (Lux) Equity Fund - Sustainable Health Transformation (USD) P-acc

Reference Data

ISIN LU0085953304
Valor Number 855245
Bloomberg Global ID UBSEHLI LX
Fund Name UBS (Lux) Equity Fund - Sustainable Health Transformation (USD) P-acc
Fund Provider UBS Asset Management Switzerland AG, Zurich 8098 Zürich, Schweiz
E-Mail: ubs-am-wholesale-switzerland@ubs.com
Web: www.ubs.com/fonds
Fund Provider UBS Asset Management Switzerland AG, Zurich
Representative in Switzerland UBS Fund Management (Switzerland) AG
Basel
Phone: +41 61 288 49 10
Distributor(s) UBS Global Asset Management
Basel
Phone: +41 61 288 20 20
Asset Class Equities
EFC Category Equity Health Care
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The Fund’s investment objective consists in generating strong capital appreciation with a reasonable level of income, while giving due consideration to capital security and the liquidity of the Fund’s assets. This sub-fund is a Sustainability Focus Fund. This sub-fund promotes environmental and/or social characteristics and complies with Article 8 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (“SFDR”). This actively managed sub-fund invests at least two thirds of its assets worldwide in shares or other equity interests of companies in developed or emerging markets, which mainly promote United Nations Sustainable Development Goal 3 (Good Health and Well-Being). The focus is on companies that capitalise on healthcare transformation.
Peculiarities

Fund Prices

Current Price * 516.53 USD 06.01.2026
Previous Price * 502.60 USD 05.01.2026
52 Week High * 516.53 USD 06.01.2026
52 Week Low * 393.93 USD 07.04.2025
NAV * 516.53 USD 06.01.2026
Issue Price * 516.53 USD 06.01.2026
Redemption Price * 516.53 USD 06.01.2026
Closing Price *
Indicative Minimum Price
Fund Assets *** 251,375,629
Unit/Share Assets *** 103,427,576
Trading Information SIX

Performance

YTD Performance +2.47% 31.12.2025
06.01.2026
YTD Performance (in CHF) +2.77% 31.12.2025
06.01.2026
1 month +3.47% 08.12.2025
06.01.2026
3 months +11.02% 06.10.2025
06.01.2026
6 months +22.36% 07.07.2025
06.01.2026
1 year +20.85% 06.01.2025
06.01.2026
2 years +20.29% 08.01.2024
06.01.2026
3 years +34.34% 06.01.2023
06.01.2026
5 years +41.28% 06.01.2021
06.01.2026

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI 6.81
ADDI Date 06.01.2026

Top 10 Holdings ***

Eli Lilly and Co 9.73%
AstraZeneca PLC 8.06%
UnitedHealth Group Inc 5.67%
Alcon Inc 5.08%
Sandoz Group AG Registered Shares 4.90%
Koninklijke Philips NV 4.78%
Intuitive Surgical Inc 4.76%
Chugai Pharmaceutical Co Ltd 4.24%
Novartis AG Registered Shares 3.99%
Vertex Pharmaceuticals Inc 3.36%
Last data update 30.11.2025

Cost / Risk

TER 1.80%
TER date 30.11.2024
Performance Fee *** 0.00%
PTR
Max. Management Fee *** 1.37%
Ongoing Charges *** 1.79%
SRRI ***
SRRI date *** 30.11.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)